
Researchers at the University of East Anglia have developed a new targeted cancer therapy which utilises nanoparticles to deliver treatment …

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …

Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt …

Manufacturing of pharmaceuticals takes place all over the world and the health of patients globally is at stake. Ben Hargreaves …

Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …

Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …

Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …

Samantha O’Shea explains some of the challenges she faces caring for her son, Ethan, who lives with a debilitating but …

Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …

Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border royalties.The …

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …

Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …